Loading...
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
The Wnt pathway is a key element of bone remodeling; its activation stimulates bone formation and inhibits bone resorption. The discovery of sclerostin, a natural antagonist of the Wnt pathway, promoted the development of romosozumab, a human monoclonal antibody directed against sclerostin, as well...
Saved in:
| Published in: | J Clin Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694131/ https://ncbi.nlm.nih.gov/pubmed/33114755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113439 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|